STEPHANIE TAFFLINGER: Open Payments
NPI 1619669900 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 35 payments from 16 companies in 2025. Trend: 2023 $105 · 2024 $1,976 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 5 | $382 |
| Corcept Therapeutics | 4 | $86 |
| Tandem Diabetes Care, Inc. | 5 | $71 |
| Mannkind Corporation | 2 | $62 |
| Amneal Pharmaceuticals LLC | 3 | $58 |
| CeQur Corporation | 1 | $56 |
| Lilly USA, LLC | 3 | $54 |
| Novo Nordisk Inc | 3 | $53 |
| SANOFI-AVENTIS U.S. LLC | 2 | $39 |
| Averitas Pharma Inc. | 1 | $32 |
Products named: TWIIST, Korlym, t:slim X2 Insulin Pump with Control-IQ, AFREZZA, UNITHROID, CeQur Simplicity, MOUNJARO, Ozempic.
Industry payments across IN — which companies pay providers there.
